"1177-1062"[Journal] - Search Results

Year	Number of Results
2006	41
2007	41
2008	38
2009	34
2010	42
2011	32
2012	37
2013	37
2014	68
2015	46
2016	60
2017	65
2018	64
2019	66
2020	69
2021	70
2022	69
2023	70
2024	82
2025	78
2026	41

1

Genetic Determinants of Childhood Obesity.

Littleton SH, Berkowitz RI, Grant SFA. Littleton SH, et al. Mol Diagn Ther. 2020 Dec;24(6):653-663. doi: 10.1007/s40291-020-00496-1. Epub 2020 Oct 1. Mol Diagn Ther. 2020. PMID: 33006084 Free PMC article. Review.

2

Oxidative Stress and Potential Antioxidant Therapies in Vitiligo: A Narrative Review.

Białczyk A, Wełniak A, Kamińska B, Czajkowski R. Białczyk A, et al. Mol Diagn Ther. 2023 Nov;27(6):723-739. doi: 10.1007/s40291-023-00672-z. Epub 2023 Sep 22. Mol Diagn Ther. 2023. PMID: 37737953 Free PMC article. Review.

3

Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections: Advances and Challenges.

Su LD, Chiu CY, Gaston D, Hogan CA, Miller S, Simon DW, Thakur KT, Yang S, Piantadosi A. Su LD, et al. Mol Diagn Ther. 2024 Sep;28(5):513-523. doi: 10.1007/s40291-024-00727-9. Epub 2024 Jul 11. Mol Diagn Ther. 2024. PMID: 38992308 Free PMC article. Review.

4

Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy.

Colella P. Colella P. Mol Diagn Ther. 2024 Nov;28(6):703-719. doi: 10.1007/s40291-024-00733-x. Epub 2024 Aug 12. Mol Diagn Ther. 2024. PMID: 39134822 Review.

5

Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis.

Melosky B, Kambartel K, Häntschel M, Bennetts M, Nickens DJ, Brinkmann J, Kayser A, Moran M, Cappuzzo F. Melosky B, et al. Mol Diagn Ther. 2022 Jan;26(1):7-18. doi: 10.1007/s40291-021-00563-1. Epub 2021 Nov 23. Mol Diagn Ther. 2022. PMID: 34813053 Free PMC article.

6

Omidubicel: First Approval.

Heo YA. Heo YA. Mol Diagn Ther. 2023 Sep;27(5):637-642. doi: 10.1007/s40291-023-00662-1. Epub 2023 Jun 24. Mol Diagn Ther. 2023. PMID: 37354365 Review.

7

Tabelecleucel: First Approval.

Keam SJ. Keam SJ. Mol Diagn Ther. 2023 May;27(3):425-431. doi: 10.1007/s40291-023-00648-z. Epub 2023 Apr 5. Mol Diagn Ther. 2023. PMID: 37016096 Review.

8

Lifileucel: First Approval.

Keam SJ. Keam SJ. Mol Diagn Ther. 2024 May;28(3):339-344. doi: 10.1007/s40291-024-00708-y. Epub 2024 Apr 16. Mol Diagn Ther. 2024. PMID: 38625642 Review.

9

Psoriasis: A Multidimensional Review of Onset, Progression, Treatment, and the Evolution of Disease Models.

Pan Y, Zou J, Hu T, Zhu Z, Zhang Z, Chen W, Lu Y. Pan Y, et al. Mol Diagn Ther. 2025 May;29(3):345-366. doi: 10.1007/s40291-025-00776-8. Epub 2025 Apr 1. Mol Diagn Ther. 2025. PMID: 40167939 Review.

10

Dorocubicel: First Approval.

Lee A. Lee A. Mol Diagn Ther. 2026 Jan;30(1):173-176. doi: 10.1007/s40291-025-00824-3. Epub 2025 Dec 3. Mol Diagn Ther. 2026. PMID: 41335182 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,083 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,083 results

Results by year